EyeCon 2026 Banner
|Articles|February 15, 2004

New drug application sought for combination IOP medication

Alcon is asking the FDA to approve a new drug application for its travoprost 0.004% plus timolol 0.5% fixed combination (TTFC) for the reduction of IOP in the treatment of glaucoma.


Latest CME